CollPlant to Participate in the Upcoming 27th Annual H.C. Wainwright Global Investment Conference
CollPlant Biotechnologies (NASDAQ: CLGN), a company focused on regenerative and aesthetics medicine using non-animal-derived recombinant human collagen technology, has announced its participation in the 27th Annual H.C. Wainwright Global Investment Conference.
The conference will take place on September 8-9, 2025, at the Lotte New York Palace Hotel. Senior management will be available for one-on-one meetings with investors, which can be arranged through H.C. Wainwright representatives or via meetings@hcwco.com.
CollPlant Biotechnologies (NASDAQ: CLGN), azienda specializzata in medicina rigenerativa ed estetica che utilizza tecnologia di collagene umano ricombinante di origine non animale, ha annunciato la sua partecipazione alla 27ª Annuale H.C. Wainwright Global Investment Conference.
La conferenza si terrà l’8 e il 9 settembre 2025 presso il Lotte New York Palace Hotel. Il top management sarà disponibile per incontri one-to-one con gli investitori, prenotabili tramite i rappresentanti di H.C. Wainwright o scrivendo a meetings@hcwco.com.
CollPlant Biotechnologies (NASDAQ: CLGN), compañía centrada en medicina regenerativa y estética que utiliza tecnología de colágeno humano recombinante de origen no animal, ha anunciado su participación en la 27.ª Conferencia Anual Global de Inversión H.C. Wainwright.
La conferencia se celebrará los 8 y 9 de septiembre de 2025 en el Lotte New York Palace Hotel. La alta dirección estará disponible para reuniones individuales con inversores, que pueden organizarse a través de los representantes de H.C. Wainwright o en meetings@hcwco.com.
CollPlant Biotechnologies (NASDAQ: CLGN)는 동물 유래가 아닌 재조합 인간 콜라겐 기술을 활용한 재생 및 미용 의학에 주력하는 기업으로, 제27회 연례 H.C. Wainwright 글로벌 투자 컨퍼런스에 참가한다고 발표했습니다.
컨퍼런스는 2025년 9월 8일~9일에 롯데 뉴욕 팰리스 호텔에서 열립니다. 경영진은 투자자와의 일대일 미팅에 응할 예정이며, H.C. Wainwright 담당자를 통해 또는 meetings@hcwco.com으로 예약할 수 있습니다.
CollPlant Biotechnologies (NASDAQ: CLGN), société spécialisée en médecine régénérative et esthétique utilisant une technologie de collagène humain recombinant d’origine non animale, a annoncé sa participation à la 27e Conférence Annuelle Mondiale H.C. Wainwright.
La conférence se déroulera les 8 et 9 septembre 2025 au Lotte New York Palace Hotel. La direction sera disponible pour des réunions individuelles avec des investisseurs, pouvant être organisées via les représentants de H.C. Wainwright ou à l’adresse meetings@hcwco.com.
CollPlant Biotechnologies (NASDAQ: CLGN), ein Unternehmen, das sich auf regenerative und ästhetische Medizin mit nicht-tierischem rekombinantem humanen Kollagen konzentriert, hat seine Teilnahme an der 27. jährlichen H.C. Wainwright Global Investment Conference angekündigt.
Die Konferenz findet am 8. und 9. September 2025 im Lotte New York Palace Hotel statt. Die Geschäftsführung steht für Einzelgespräche mit Investoren zur Verfügung, die über die Vertreter von H.C. Wainwright oder per E-Mail an meetings@hcwco.com arrangiert werden können.
- None.
- None.
REHOVOT,
Investors attending the event may request a one-on-one meeting with CollPlant through their H.C. Wainwright representative or e-mail meetings@hcwco.com.
About CollPlant
CollPlant is a regenerative and aesthetic medicine company ushering in a new era of medical solutions with a focus on 3D bioprinting of tissues and organs, tissue repair and medical aesthetics. The Company's products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant-based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing.
In 2021, CollPlant entered into a development and global commercialization agreement for dermal and soft tissue fillers with Allergan, an AbbVie company, the global leader in the dermal filler market.
For more information about CollPlant, visit http://www.collplant.com.
Contacts
CollPlant:
Eran Rotem
Deputy CEO & CFO
+972-73-2325600
Eran@collplant.com
Investors:
LifeSci Advisors
Dan Ferry
daniel@lifesciadvisors.com
Logo: https://mma.prnewswire.com/media/2217353/CollPlant_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/collplant-to-participate-in-the-upcoming-27th-annual-hc-wainwright-global-investment-conference-302537524.html
SOURCE CollPlant
FAQ
When is CollPlant (NASDAQ:CLGN) presenting at the H.C. Wainwright Conference 2025?
How can investors meet with CollPlant management at the H.C. Wainwright Conference?
What is CollPlant Biotechnologies' main technology focus?
Where will the H.C. Wainwright Global Investment Conference 2025 be held?
